Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: arthritis

Reactive Arthritis: Chronic or Self-Limiting?

Michael J. Cammarata, MD  |  June 8, 2025

Reactive arthritis has proved to be a diagnostic & therapeutic challenge due to its diverse presentations.

Filed under:Axial SpondyloarthritisConditions Tagged with:biologic DMARDsdisease managementextra-articular manifestationsGlucocorticoidsHLA-B27infectious etiologymusculoskeletal manifestationsNSAIDsReactive arthritisspondyloarthritissulfasalazine

Psychosocial Factors & Pain in Hand Osteoarthritis

Ruth Jessen Hickman, MD  |  June 7, 2025

Attention to factors beyond the standard nociceptive model of painin patients with hand OA, including psychosocial considerations &other comorbidities, may impact a patient’s pain perception &pain course.

Filed under:AnalgesicsConditionsOsteoarthritis and Bone Disorders Tagged with:biopsychosocialChronic paincoping styleshand osteoarthritishand painNonsteroidal anti-inflammatory drugs (NSAIDs)NSAIDsPain Managementpain perceptionpatient education

New Editor in Chief Has Expansive Vision for Arthritis & Rheumatology

Leslie Mertz, PhD   |  May 30, 2025

Incoming Arthritis & Rheumatology Editor-in-Chief Dr. S. Louis Bridges Jr., MD, PhD, discusses his path to rheumatology and outlines his vision for the journal.

Filed under:From the CollegeResearch Rheum Tagged with:Arthritis & RheumatologyDr. S. Louis Bridges Jr.

Advocates for Arthritis 2025: By the Numbers

From the College  |  May 18, 2025

On May 6, more than 100 members of the rheumatology community participated in 118 meetings with lawmakers from 26 states—urging members of Congress to sustain research funding, address cuts and stabilize Medicare reimbursement, enact pharmacy benefit manager (PBM) reforms and protect Medicaid funding. See photos and stories from the event.

Filed under:American College of RheumatologyLegislation & AdvocacyProfessional Topics Tagged with:Advocates for Arthritis

ACR, Arthritis Foundation Host Congressional Briefing to Champion Rheumatology Research

From the College  |  May 17, 2025

The May 6 event brought together patients, physicians and advocates to challenge misconceptions and advocate for sustained investment in rheumatology research.

Filed under:Legislation & AdvocacyPatient Perspective Tagged with:ACR advocacyarthritis research

Advocates for Arthritis 2025: United for the Future of Rheumatology Care

From the College  |  May 6, 2025

In visits to Congress members and staff, more than 120 ACR/ARP members and patients urged action to improve patient access to quality treatment. The meetings included discussions about the importance of research funding, ensuring adequate Medicare reimbursement, protecting Medicaid, and making PBMs more transparent and accountable. It’s not too late to amplify their message.

Filed under:From the CollegeLegislation & AdvocacyPractice Support Tagged with:Advocates for Arthritis

Advocates for Arthritis 2025: Preview of Key Issues

From the College  |  April 21, 2025

When ACR volunteer leaders, members and patient advocates head to Capitol Hill in May, they will urge members of Congress to protect Medicare and Medicaid against cuts, restore research funding and reform pharmacy benefit managers for better transparency and accountability.

Filed under:Legislation & Advocacy Tagged with:Advocates for Arthritis

Semaglutatide for Patients with Knee Osteoarthritis?

Bryn Nelson, PhD  |  April 8, 2025

Based on decades of data from dietary and other lifestyle interventions, doctors have long known that significant weight loss can be an effective treatment for people who are overweight and have knee osteoarthritis (OA). One meta-analysis showed that OA pain, function and stiffness scores improved by 2% for every 1% in lost weight.1 But the…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone DisordersResearch Rheum Tagged with:knee osteoarthritisResearch Reviewresearch reviewssemaglutideweight loss

What Can I Eat or Not Eat to Cure My Arthritis?

Kim Arrey, DtP  |  April 7, 2025

“What can I eliminate from my diet to cure my arthritis?” is the question every client with arthritis asks me. Numerous case reports document patients who achieved lower markers of inflammation and reduced pain and stiffness associated with the removal of one or two food groups from a diet, but historically, no compelling evidence has…

Filed under:Conditions Tagged with:Dietgut microbiomegut microbiotaMediterranean dietnutrition

Looking Ahead to Advocates for Arthritis 2025

From the College  |  April 5, 2025

This May, more than 120 ACR leaders, fellows and patients with rheumatic disease will converge in Washington, D.C., to lobby Congress on issues including protecting Medicare and Medicaid, National Institutes of Health research funding and pharmacy benefit manager reform.

Filed under:Legislation & Advocacy Tagged with:Advocates for Arthritis

  • 1
  • 2
  • 3
  • …
  • 483
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences